Atlas Trials

Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

Clinical trial NCT00082914 · COMPLETED

Trial details

NCT number
NCT00082914
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney CancerMelanoma (Skin)
Start date
2004-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.